Should an institution that has commercial rights in a new drug or device be allowed to evaluate the technology?

Published

Journal Article

BACKGROUND TO THE DEBATE: In the United States, the passage of the Bayh-Dole Act in 1980 encouraged universities to license inventions for commercial development. Although this financial incentive can stimulate academic researchers to discover new drugs and devices, there is concern that the possibility of monetary reward could distort investigators' objectivity.

Full Text

Duke Authors

Cited Authors

  • McKinney, R; Korn, D

Published Date

  • January 2005

Published In

Volume / Issue

  • 2 / 1

Start / End Page

  • e9 -

PubMed ID

  • 15696219

Pubmed Central ID

  • 15696219

Electronic International Standard Serial Number (EISSN)

  • 1549-1676

Digital Object Identifier (DOI)

  • 10.1371/journal.pmed.0020009

Language

  • eng

Conference Location

  • United States